Home › Funds › Soleus Capital Management, L.P. › KOD
Soleus Capital Management, L.P. position in KOD
KODIAK SCIENCES INC · Health Care
Soleus Capital Management, L.P. reported holding 286,966 shares of KOD (KODIAK SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$27.2M, representing 0.97% of its reported portfolio and ranking #25 among its reported holdings. Soleus Capital Management, L.P. has disclosed KOD holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s KOD position evolved
Soleus Capital Management, L.P. first disclosed a stake in KOD in Q3 2025 at 19,644 shares (US$322K). The position peaked in Q3 2026 at 286,966 shares, worth US$27.2M. Across 3 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 286,966 shares valued at US$27.2M. Notable position changes include a 205% increase in Q4 2025 (shares rose 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 19.64K | $321.57K | New |
| Q4 2025 | 60.00K | $1.68M | Add |
| Q3 2026 | 286.97K | $27.20M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KOD and 13F data
KOD (KODIAK SCIENCES INC) is a Health Care company. 83 other funds we track also report a position in KOD — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.07B), RTW INVESTMENTS, LP (US$141.1M), Boxer Capital Management, LLC (US$140.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KOD
- BAKER BROS. ADVISORS LP 21.86M sh · $2.07B · Q3 2026
- RTW INVESTMENTS, LP 1.49M sh · $141.06M · Q3 2026
- Boxer Capital Management, LLC 1.48M sh · $140.08M · Q3 2026
- TCG Crossover Management, LLC 1.45M sh · $137.04M · Q3 2026
- BRAIDWELL LP 1.09M sh · $102.93M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 750.17K sh · $71.12M · Q3 2026
- Board of Trustees of The Leland Stanford Junior University 691.77K sh · $65.58M · Q3 2026
- Bellevue Group AG 460.42K sh · $43.65M · Q3 2026
- Squadron Capital Management LLC 270.00K sh · $25.60M · Q3 2026
- ADAPT Investment Managers SA 200.00K sh · $18.96M · Q3 2026
- Ghisallo Capital Management LLC 200.00K sh · $18.96M · Q3 2026
- Parkman Healthcare Partners LLC 186.00K sh · $17.63M · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held KOD?
Soleus Capital Management, L.P. has disclosed KOD holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
What is Soleus Capital Management, L.P.'s current position in KOD?
As of Q3 2026, Soleus Capital Management, L.P. holds 286.97K shares of KOD (KODIAK SCIENCES INC), valued at $27.20M, representing 0.97% of its reported portfolio and ranking #25.
Has Soleus Capital Management, L.P. been buying or selling KOD?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. newly opened its position in KOD. The position peaked in Q3 2026 at 286.97K shares.
Which other funds hold KOD?
Other major institutional holders of KOD include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 83 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.